Lemonade Shares Slide to Lowest Level in a Year

The insurtech's stock fell 6.55% Friday and has lost more than half its value since the start of the year.

Updated on Nov. 1, 2026 in Public Companies

Lemonade Shares Slide to Lowest Level in a Year

Lemonade's share price fell 6.55% on Friday on Wall Street, reaching its lowest level in more than a year. The insurance technology company, with a market capitalization of $3.3 billion, has lost more than half its value since the start of the year.

Why it matters

The decline comes as the company is set to publish third quarter financial results, a key checkpoint for investors weighing its path toward profitability. Analyst sentiment is mixed, with most maintaining a neutral stance.

Analysts expect third quarter revenue of $322 million, up 65.8%, with net loss per share widening from $0.51 to $0.58. Price targets range from $38 to $92, with the lowest about 11.5% below the current price.

The players

Lemonade

An Israeli insurance technology company that uses artificial intelligence to sell and manage insurance policies, listed on Wall Street.

Daniel Schreiber

Cofounder and chief executive officer of Lemonade, who helped launch the company as a digital-first insurer.

Shai Wininger

Cofounder and president of Lemonade, who together with Schreiber built the company's insurance platform.

The details

Shares fell in Wall Street trading on Friday, marking the lowest level for the stock in more than a year. Lemonade, which was cofounded by CEO Daniel Schreiber and president Shai Wininger, is set to report third quarter results on Thursday, and the company expects positive adjusted EBITDA by the fourth quarter.

Timeline

  1. Start of 2026: Shares were trading especially high at the beginning of the year.

  2. Friday, October 30, 2026: Shares fell 6.55% on Wall Street.

  3. Thursday, November 5, 2026: Lemonade publishes third quarter financial results.

  4. Fourth quarter of 2026: The company expects positive adjusted EBITDA.

Market Landscape

Lemonade's slide mirrors the broader correction that has pulled many high-valuation insurtech and technology stocks down since 2021. Its decline places the company among growth-focused insurers whose shares have been repriced as investors demand nearer-term profitability.

Investors holding Lemonade shares face a stock that has lost more than half its value this year, so the upcoming earnings release is a near-term checkpoint for their positions. Retail investors weighing exposure should review the company's guidance and the mixed analyst outlook before adjusting their holdings.

The takeaway

Growth stocks that trade at high valuations are often repriced sharply when profitability timelines slip, so investors should weigh a company's path to positive earnings against its current price. Monitoring quarterly results against analyst projections is a practical way to track whether that path is on schedule.

What happens next

Lemonade will publish its third quarter financial results on Thursday, November 5, 2026, which will give investors a fuller picture of its revenue and loss trajectory.

Further reading

Track more stock movements and corporate earnings in our Public Companies coverage.

Source note: This article includes information reported by Globes.